언어 선택
무료 등록

G4S

제품 문의

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Zibotentan/DapagliflozinPhase 3 ClinicalAstrazeneca Ab, AstraZeneca global R & D (China) Co LtdAlbuminuria; Kidney Diseases; Renal Insufficiency, Chronic
상세
PatecibartGMA-301; GMA-301-A; GMA-301-BPhase 2 ClinicalGmax Biopharm LlcPulmonary Arterial Hypertension
상세
SC-0062SC-0062Phase 2 ClinicalShijiazhuang Zhikang Hongren New Drug Development Co LtdGlomerulonephritis, IGA; Altitude Sickness; Kidney Diseases; Pulmonary Arterial Hypertension; Diabetic Nephropathies
상세
ZibotentanZD-4054; AZD-4054Phase 2 ClinicalAstrazeneca PlcHepatic Insufficiency; Scleroderma, Limited; Neoplasm Metastasis; Peripheral Arterial Disease; Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Renal Insufficiency, Chronic; Lung Neoplasms; Colorectal Neoplasms; Solid tumours; Prostatic Neoplasms; Hypertension, Portal; Scleroderma, Systemic; Liver Cirrhosis; Intermittent Claudication; Renal Insufficiency; Ovarian Neoplasms; Microvascular Angina
상세
BQ-123CGS-26343; BQ-123; PMZ-2123Phase 1 ClinicalMidwestern UniversityHypertension, Pulmonary; Heart Failure; ST Elevation Myocardial Infarction; Pain; Diabetic Ketoacidosis; Coronary Artery Disease; Proteinuria; Metabolic Syndrome; Hypoxia, Brain; Hypertension; Cardiovascular Diseases; Renal Insufficiency, Chronic; Multiple System Atrophy; Pure Autonomic Failure
상세
GMA-131GMA-131Phase 1 ClinicalGmax Biopharm Llc, Gmaxx Biologics LtdDiabetic Nephropathies
상세
SAL-0120SAL0120; SAL-0120Phase 1 ClinicalShenzhen Salubris Pharmaceuticals Co LtdGlomerulonephritis, IGA; Hypertension; Essential Hypertension
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Clazosentan SodiumRo-61-1790; ACT-108475; AXV-034; VML-588; AXV-034343ApprovedF. Hoffmann-La Roche LtdPivlazJapanSubarachnoid Hemorrhage; Vasospasm, Intracranial; Cerebral Infarction; Brain IschemiaIdorsia Pharmaceuticals Ltd2022-01-20Brain Ischemia; Aneurysm; Vasospasm, Intracranial; Subarachnoid Hemorrhage; Cerebral Infarction
상세
Macitentan/TadalafilApprovedActelion Pharmaceuticals LtdOPSYNVIUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2024-03-22Pulmonary Arterial Hypertension
상세
AmbrisentanLU-208075; BSF-208075; GSK-132576AApprovedAbbott LaboratoriesLetairis, Volibris, 凡瑞克United StatesPulmonary Arterial HypertensionGilead Sciences Inc2007-06-15Hypertension, Pulmonary; Sarcoidosis; Hypertension, Portal; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Thromboembolism; Hypertension; Ascites; Hypoxia; Acute Kidney Injury; Pulmonary Arterial Hypertension; Vascular Diseases; Anemia, Sickle Cell; Hepatorenal Syndrome
상세
SparsentanRE-021; PS-433540; BMS-346567ApprovedBristol-Myers Squibb CompanyFilspariUnited StatesGlomerulonephritis, IGATravere Therapeutics Inc2023-02-17Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Vasculitis; Autoimmune Diseases; Nephrosis, Lipoid; Hypertension; Immune System Diseases; Glomerulosclerosis, Focal Segmental; Cardiovascular Diseases; Nephritis, Hereditary; Glomerulonephritis
상세
Bosentan HydrateACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039ApprovedF. Hoffmann-La Roche LtdStayveer, 全可利, TracleerUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Ltd2001-11-20Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial
상세
MacitentanACT-064992; Actelion-1; JNJ-67896062ApprovedActelion Pharmaceuticals LtdZependo, Opsumit, 傲朴舒United StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2013-10-18Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease
상세
AprocitentanACT-132577; AC-080; JNJ-2820ApprovedIdorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals LtdTRYVIOUnited StatesHypertensionIdorsia Pharmaceuticals Ltd2024-03-19Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic
상세
  • 제품 문의
  • 시판 약물 정보
  • 임상 약물 정보
공유하기:

참여하기법적 규정사이트맵개인정보 정책약관 및 조건
웹사이트 피드백
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호